The purpose our study was to determine the protective effects of mitochondria division inhibitor 1 (Mdivi1) in Alzheimer’s disease (AD). Mdivi1 is hypothesized to reduce excessive fragmentation of mitochondria and mitochondrial dysfunction in AD neurons. Very little is known about whether Mdivi1 can confer protective effects in AD. In the present study, we sought to determine the protective effects of Mdivi1 against amyloid-β (Aβ)- and mitochondrial fission protein, dynamin-related protein 1 (Drp1)-induced excessive fragmentation of mitochondria in AD progression. We also studied preventive (Mdivi1+Aβ42) and intervention (Aβ42+Mdivi1) effects against Aβ42 in N2a cells. Using real-time RT-PCR and immunoblotting analysis, we measured mRNA and protein levels of mitochondrial dynamics, mitochondrial biogenesis, and synaptic genes. We also assessed mitochondrial function by measuring H2O2, lipid peroxidation, cytochrome oxidase activity, and mitochondrial ATP. MTT assays were used to assess the cell viability. Aβ42 was found to impair mitochondrial dynamics, lower mitochondrial biogenesis, lower synaptic activity, and lower mitochondrial function. On the contrary, Mdivi1 enhanced mitochondrial fusion activity, lowered fission machinery, and increased biogenesis and synaptic proteins. Mitochondrial function and cell viability were elevated in Mdivi1-treated cells. Interestingly, Mdivi1 pre- and post-treated cells treated with Aβ showed reduced mitochondrial dysfunction, and maintained cell viability, mitochondrial dynamics, mitochondrial biogenesis, and synaptic activity. The protective effects of Mdivi1 were stronger in N2a+Aβ42 pre-treated with Mdivi1, than in N2a+Aβ42 cells than Mdivi1 post-treated cells, indicating that Mdivi1 works better in prevention than treatment in AD like neurons.
ReddyPH, ManczakM, YinX, GradyMC, MitchellA, KandimallaR, KuruvaCS (2016) Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer’s disease. J Investig Med64, 1220–1234.
7.
ReddyPH, TripathiR, TroungQ, TirumalaK, ReddyTP, AnekondaV, ShirendebUP, CalkinsMJ, ReddyAP, MaoP, ManczakM (2012) Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta1822, 639–649.
8.
MaoP, ReddyPH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: Implications for early intervention and therapeutics. Biochim Biophys Acta1812, 1359–1370.
MaurerI, ZierzS, MöllerHJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging21, 455–462.
DeviL, PrabhuBM, GalatiDF, AvadhaniNG, AnandatheerthavaradaHK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction. J Neurosci26, 9057–9068.
15.
ManczakM, AnekondaTS, HensonE, ParkBS, QuinnJ, ReddyPH (2006) Mitochondria are a direct site of Abeta accumulation in Alzheimer’s disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet15, 1437–1449.
16.
ReddyPH, BealMF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol Med14, 45–53.
17.
LinMT, SimonDK, AhnCH, KimLM, BealMF (2002) High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer’s disease brain. Hum Mol Genet11, 133–145.
18.
CoskunPE, BealMF, WallaceDC (2004) Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A101, 10726–11031.
19.
ChandrasekaranK, GiordanoT, BradyDR, StollJ, MartinLJ, RapoportSI (1994) Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res24, 336–340.
20.
ReddyPH, McWeeneyS, ParkBS, ManczakM, GutalaRV, PartoviD, JungY, YauV, SearlesR, MoriM, QuinJF (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer’s disease. Hum Mol Genet13, 1225–1240.
21.
ManczakM, CalkinsMJ, ReddyPH (2011) impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer’s disease: Implications for neuronal damage. Hum Mol Genet20, 2495–2509.
22.
ManczakM, ParkBS, JungY, ReddyPH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease: Implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med5, 147–162.
CalkinsMJ, ReddyPH (2011) Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer’s disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage. Biochim Biophys Acta1812, 1182–1189.
25.
CalkinsMJ, ManczakM, MaoP, ShirendebU, ReddyPH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer’s disease. Hum Mol Genet20, 4515–4529.
26.
WangX, SuB, SiedlakSL, MoreiraPI, FujiokaH, WangY, CasadesusG, ZhuX (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A105, 19318–19323.
27.
WangX, SuB, LeeHG, LiX, PerryG, SmithMA, ZhuX (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci29, 9090–9103.
28.
ManczakM, KandimallaR, FryD, SesakiH, ReddyPH (2016) Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease. Hum Mol Genet25, 5148–5166.
29.
KandimallaR, ManczakM, FryD, SuneethaY, SesakiH, ReddyPH (2016) Reduced dynamin-related protein 1 protects against phosphorylated tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease. Hum Mol Genet25, 4881–4897.
30.
ReddyPH (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Exp Neurol218, 286–292.
31.
TrushinaE, NemutluE, ZhangS, ChristensenT, CampJ, MesaJ, SiddiquiA, TamuraY, SesakiH, WengenackTM, DzejaPP, PodusloJF (2012) Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer’s disease. PLoS One7, e32737.
32.
ReddyPH (2014) Increased mitochondrial fission and neuronal dysfunction in Huntington’s disease: Implications for molecular inhibitors of excessive mitochondrial fission. Drug Discov Today19, 951–955.
33.
ReddyPH (2014) Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction. J Alzheimers Dis40, 245–256.
34.
Cassidy-StoneA, ChipukJE, IngermanE, SongC, YooC, KuwanaT, KurthMJ, ShawJT, HinshawJE, GreenDR, NunnariJ (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell14, 193–204.
35.
MaciaE, EhrlichM, MassolR, BoucrotE, BrunnerC, KirchhausenT (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell10, 839–850.
36.
QiX, QvitN, SuYC, Mochly-RosenD (2013) A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci126, 789–802.
37.
QiuX, CaoL, YangX, ZhaoX, LiuX, HanY, XueY, JiangH, ChiZ (2013) Role of mitochondrial fission in neuronal injury in pilocarpine-induced epileptic rats. Neuroscience245, 157–165.
38.
OngSB, SubrayanS, LimSY, YellonDM, DavidsonSM, HausenloyDJ (2010) Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation121, 2012–2022.
ParkSW, KimKY, LindseyJD, DaiY, HeoH, NguyenDH, EllismanMH, WeinrebRN, JuWK (2011) A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina. Invest Ophthalmol Vis Sci52, 2837–2843.
41.
XieN, WangC, LianY, ZhangH, WuC, ZhangQ (2013) A selective inhibitor of Drp1, mdivi-1, protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett545, 64–68.
42.
WapplerEA, InstitorisA, DuttaS, KatakamPV, BusijaDW (2013) Mitochondrial dynamics associated with oxygen-glucose deprivation in rat primary neuronal cultures. PLoS One8, e63206.
43.
ChlystunM, CampanellaM, LawAL, DuchenMR, FatimathasL, LevineTP, GerkeV, MossSE (2013) Regulation of mitochondrial morphogenesis by annexin A6. PLoS One8, e53774.
44.
ManczakM, ReddyPH (2015) Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington’s disease. Hum Mol Genet24, 7308–7325.
45.
SilvaDF, SelfridgeJE, LuJ, EL, RoyN, HutflesL, BurnsJM, MichaelisEK, YanS, CardosoSM, SwerdlowRH (2013) Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet22, 3931–3946.
46.
ReddyPH (2006) Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer’s disease. J Neurochem96, 1–13.
47.
AleardiAM, BenardG, AugereauO, MalgatM, TalbotJC, MazatJP, LetellierT, Dachary-PrigentJ, SolainiGC, RossignolR (2005) Gradual alteration of mitochondrial structure and function by beta-amyloids: Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr37, 207–225.
WangX, YanMH, FujiokaH, LiuJ, Wilson-DelfosseA, ChenSG, PerryG, CasadesusG, ZhuX (2012) LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet21, 1931–1944.
56.
StafaK, TsikaE, MoserR, MussoA, GlauserL, JonesA, BiskupS, XiongY, BandopadhyayR, DawsonVL, DawsonTM, MooreDJ (2014) Functional interaction of Parkinson’s disease-associated LRRK2 with members of the dynamin GTPase superfamily. Hum Mol Genet23, 2055–2077.
57.
SadeghianM, MastroliaV, Rezaei HaddadA, MosleyA, MullaliG, SchizaD, SajicM, HargreavesI, HealesS, DuchenMR, SmithKJ (2016) Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Re6, 33249.
58.
MagranéJ, SahawnehMA, PrzedborskiS, EstévezÁG, ManfrediG (2012) Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci32, 229–242.
